SPORTS MEDICINE – GLOBAL ANALYSIS AND MARKET FORECASTS · reference code gdme206mar | publication...

REFERENCE CODE GDME206MAR | PUBLICAT ION DATE MARCH 2014

SPORTS MEDICINE – GLOBAL ANALYSIS AND MARKET FORECASTS

Sports Medicine – Global Analysis and Market Forecasts 2 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.


Executive Summary

Arthroscopy Devices, Key Metrics in the Major Markets, 2013–2020 (2013) Arthroscopic Procedure Volume Globally

2013 Global Market Sales for Arthroscopic Implants Market ($m)

2013 Global Market Sales for Arthroscopic Capital Equipment Market ($m)

US (implants)

US (capital equipment)

5EU (implants)

5EU (capital equipment)

Asia-Pacific (implants)

Asia-Pacific (capital equipment)

Brazil (implants)

Brazil (capital equipment)

Key Events (2013–2020)

(2013) Smith & Nephew acquires ArthroCare for $1.7bn.

(2013) Smith & Nephew launches several suture anchor products in 2013, such as Healicoil.

(2013) Arthrex ordered to stop selling patent-infringing suture anchors.

(2013) Stryker launches Iconix all-suture anchor systems.

(2014) Wright Medical sheds its large joint reconstruction business and snaps up two extremity players, expanding its ankle business.

Competitive Assessment

Number of Devices in Marketing Phase

2020 Global Market Sales for Arthroscopic Implants Market ($m)

2020 Global Market Sales for Arthroscopic Capital Equipment Market ($m)

US (implants)

US (capital equipment)

5EU (implants)

5EU (capital equipment)

Asia-Pacific (implants)

Asia-Pacific (capital equipment)

Brazil (implants)

Brazil (capital equipment)

Source: GlobalData, based on primary research interviews with leading orthopedic sports medicine surgeons in 10 markets (US, France, Germany, Italy, Spain, UK, Japan, Brazil, China, and India) 5EU = France, Germany, Italy, Spain, and UK; Asia-Pacific = Japan, China, and India

Sales for the Arthroscopy Device Market

The arthroscopy device market consists of

implants and capital equipment. The total

arthroscopic implants market in 2013 was

estimated to be $XXm across the XX major

markets (XXMM) covered in this report: the US,

France, Germany, Italy, Spain, the UK, Japan,

Brazil, China, and India. Likewise, in 2013, the total

arthroscopic capital equipment market was

estimated to be $XXm across the XXMM. By the

end of the forecast period in 2020, implant sales

will grow to over $XXm at a Compound Annual

Growth Rate (CAGR) of XX%. Capital equipment

sales will grow to over $XXm at a CAGR of XX%.

The key drivers for the arthroscopy device market

during the forecast period are:

The growing prevalence of sports injury

through repetitive training and improper

biomechanics

Individuals in the aging segment of the

population with osteoarthritis, who are more

susceptible to sustaining injuries through

recreational activity

The growing number of individuals adopting

western sports in the emerging nations

The biologics and cell-based industry, for soft

tissue repair to treat sports injuries more

naturally, as opposed to metal implantations



Executive Summary

The movement towards more minimally-

invasive techniques, where patients and

physicians prefer arthroscopic treatment to

reduce costs for practices and reduce recovery

time for patients

Figure below presents the arthroscopy device

revenue by the percent share in each major market

during the forecast period.

Arthroscopy Device Revenue by Major Market, 2013–2020

2013

US France Germany Italy Spain UK Japan Brazil China India

2013

2020

2020

Source: GlobalData, based on primary research interviews and surveys with leading orthopedic sports medicine surgeons in 10 markets (US, France, Germany, Italy, Spain, UK, Japan, Brazil, China, and India) Top: 2013 Implants Market: $XXn and 2020 Implants Market: $XXbn Bottom: 2013 Capital Equipment Market: $XXn and 2020 Capital Equipment Market: $XXbn


Table of Contents


1 Table of Contents

1 Table of Contents ....................................................................................................................... 8

1.1 List of Tables .................................................................................................................... 16

1.2 List of Figures ................................................................................................................... 21

2 Introduction ............................................................................................................................... 23

2.1 Catalyst ............................................................................................................................. 24

2.2 Related Reports ................................................................................................................ 26

2.3 Upcoming Related Reports ............................................................................................... 26

3 Clinical Outcomes ..................................................................................................................... 27

3.1 Conservative Treatments .................................................................................................. 27

3.1.1 Immobilization and Bracing ........................................................................................... 28

3.1.2 Physical Therapy ........................................................................................................... 28

3.1.3 Muscle Stimulation ........................................................................................................ 29

3.2 Drug Therapy .................................................................................................................... 29

3.2.1 Nutritional Supplements ................................................................................................ 30

3.2.2 Analgesics and NSAIDs ................................................................................................ 30

3.2.3 Corticosteroids .............................................................................................................. 30

3.2.4 Viscosupplementation ................................................................................................... 30

3.3 Soft Tissue Repair ............................................................................................................ 31

3.4 Arthroscopy ....................................................................................................................... 33

3.5 Plates and Screws ............................................................................................................ 34

3.6 Joint Replacement ............................................................................................................ 34

4 Industry Overview ..................................................................................................................... 36

4.1 Overview ........................................................................................................................... 36

4.2 Procedure Trends ............................................................................................................. 37

4.2.1 US ................................................................................................................................. 37


Table of Contents


4.2.2 EU ................................................................................................................................. 39

4.2.3 Asia-Pacific Region ....................................................................................................... 41

4.2.4 South America............................................................................................................... 42

4.3 Market Access .................................................................................................................. 43

4.3.1 US ................................................................................................................................. 43

4.3.2 EU ................................................................................................................................. 48

4.3.3 Asia-Pacific Region ....................................................................................................... 56

4.3.4 South America............................................................................................................... 63

4.4 Disputes and Settlements ................................................................................................. 66

4.4.1 Smith & Nephew Granted an Injunction Against Arthrex ................................................ 66

4.4.2 KFx Medical and Smith & Nephew Enter Into Licensing Agreement .............................. 66

4.4.3 KFx Medical Wins Patent Infringement Lawsuit Against Arthrex .................................... 67

4.4.4 ArthroCare and Smith & Nephew Settle Legal Disputes ................................................ 67

4.5 Mergers, Acquisitions, Partnerships, and Other Deals ...................................................... 67

4.5.1 Stryker Acquires Pivot Medical ...................................................................................... 67

4.5.2 Smith & Nephew Announces Acquisition of ArthroCare ................................................. 67

4.5.3 Smith & Nephew Acquires Plato Grup Assets ............................................................... 68

4.5.4 Smith & Nephew Announces Acquisition of Its Brazil Distribution Business .................. 68

4.5.5 Kensey Nash Acquires Minority Stake in Orteq Sports Medicine ................................... 68

4.5.6 Tornier Acquires C2M Medical ...................................................................................... 68

4.5.7 Tornier Signs Licensing Agreement with T.A.G. Medical Products Corporation ............. 68

4.5.8 Biomet Acquires Cartilix ................................................................................................ 69

4.5.9 Biomet Sports Medicine Enters Into Deal With Marc Tec............................................... 69

4.6 Economic Impact .............................................................................................................. 69

4.6.1 Developed Countries ..................................................................................................... 69

4.6.2 Emerging Markets ......................................................................................................... 71

5 Unmet Needs ............................................................................................................................ 73


Table of Contents


5.1 Long-Term Clinical Data ................................................................................................... 73

5.1.1 Hip Arthroscopic Implants Clinical Data ......................................................................... 73

5.1.2 Rotator Cuff Injury Clinical Data .................................................................................... 73

5.2 Cartilage and Meniscal Repair Product Development ....................................................... 74

5.2.1 Knee Meniscus Treatment............................................................................................. 74

5.2.2 Hip Cartilage Product Development .............................................................................. 76

5.3 Biologics for Faster Healing .............................................................................................. 77

5.4 Standardization and Improvement of Instruments ............................................................. 78

5.4.1 Hip and Shoulder Instrumentation ................................................................................. 78

5.4.2 Screwdriver Standardization .......................................................................................... 78

5.5 Fellowship Training Programs ........................................................................................... 79

5.6 Advanced Materials Research .......................................................................................... 80

5.7 Bioabsorbable Technology Development .......................................................................... 81

5.8 Centralization .................................................................................................................... 83

5.9 Need for Cost-Containment............................................................................................... 83

5.10 Suture Anchor Product Development ................................................................................ 84

6 Market Opportunity Analysis ..................................................................................................... 86

6.1 Adding More Training Programs........................................................................................ 86

6.2 Product Line Extensions ................................................................................................... 86

6.3 Lack of Pricing Pressure in Sports Medicine ..................................................................... 87

6.4 Mergers and Acquisitions .................................................................................................. 88

6.5 Seasonality of Sports Medicine ......................................................................................... 89

6.6 Emerging Markets ............................................................................................................. 89

6.7 Minimally-Invasive Surgical Preference ............................................................................. 90

7 Market Drivers, Barriers and Substitutes ................................................................................... 91

7.1 Driver: Rising Prevalence .................................................................................................. 91

7.1.1 Sports-Related Injuries .................................................................................................. 91


Table of Contents


7.1.2 Aging ............................................................................................................................. 91

7.1.3 Trauma.......................................................................................................................... 92

7.2 Driver: Hip Arthroscopy ..................................................................................................... 93

7.2.1 Femoroacetabular Impingement Growth ....................................................................... 94

7.2.2 Hip Arthroscopy Fellowship Training Programs ............................................................. 95

7.3 Driver: Knee and Shoulder Arthroscopy ............................................................................ 95

7.4 Driver: Revision Surgery ................................................................................................... 96

7.5 Driver: Patient Demand and Awareness............................................................................ 97

7.6 Driver: Orthobiologics Development .................................................................................. 98

7.6.1 Bone Grafts ................................................................................................................... 98

7.6.2 Platelet-Rich Plasma ..................................................................................................... 99

7.7 Driver: Rising Competition and Innovation Through Small Players .................................... 99

7.8 Driver: Materials Development .......................................................................................... 99

7.8.1 Composite Materials and Biopolymers ........................................................................ 100

7.8.2 Bioabsorbables ........................................................................................................... 100

7.8.3 Metallic Alloys in Orthopedics ...................................................................................... 101

7.9 Barrier: Arthroscopy’s Questionable Outcomes ............................................................... 102

7.9.1 Hip Arthroscopy ........................................................................................................... 102

7.9.2 Knee Arthroscopy ........................................................................................................ 103

7.10 Barrier: Steep Learning Curve ......................................................................................... 104

7.11 Barrier: Reimbursement .................................................................................................. 104

7.12 Barrier: Burden of Rising Regulation ............................................................................... 106

7.13 Barrier: Proving Efficacy .................................................................................................. 107

7.14 Barrier: Medical Device Excise Tax ................................................................................. 108

7.15 Substitute: Open Surgery Versus Minimally-Invasive Arthroscopy .................................. 108

7.16 Substitute: Conservative Treatment Options ................................................................... 109

8 Competitive Assessment......................................................................................................... 110


Table of Contents


8.1 Overview ......................................................................................................................... 110

8.2 Marketed Products in Sports Medicine ............................................................................ 110

8.2.1 Arthrex ........................................................................................................................ 110

8.2.2 ArthroCare Corporation ............................................................................................... 119

8.2.3 Biomet ......................................................................................................................... 123

8.2.4 ConMed Corporation ................................................................................................... 128

8.2.5 DePuy Mitek ................................................................................................................ 133

8.2.6 Smith & Nephew ......................................................................................................... 137

8.2.7 Stryker......................................................................................................................... 139

8.2.8 Tornier......................................................................................................................... 142

9 Pipeline Assessment ............................................................................................................... 143

9.1 Overview ......................................................................................................................... 143

9.2 Product Profiles ............................................................................................................... 143

9.2.1 Bioretec Drug-Releasing Screws ................................................................................. 143

9.2.2 Nanova Bioabsorbable Bone Screws .......................................................................... 143

9.2.3 MinInvasive Arthroscopic Suture Passer ..................................................................... 143

9.2.4 SpineSmith Pipeline .................................................................................................... 144

9.2.5 DePuy Mitek FMS VUE ............................................................................................... 144

9.2.6 Pivot Medical Hip Arthroscopy System ........................................................................ 144

9.2.7 University of Florida Shoulder Labral Anchor Delivery System .................................... 144

9.2.8 University of California at San Diego Cartilage Regeneration Device .......................... 144

10 Clinical Trials to Watch ........................................................................................................... 145

10.1 Overview ......................................................................................................................... 145

10.2 Can Shoulder Arthroscopy Work (CSAW) Study ............................................................. 145

10.3 Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear ............................. 145

10.4 Knee Arthroscopy Cohort Southern Denmark ................................................................. 146

10.5 Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement 146


Table of Contents


10.6 Femoroacetabular Impingement Randomized Controlled Trial ........................................ 147

10.7 Multicenter ACL Revision Study (MARS) ........................................................................ 147

10.8 Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability ...................... 148

10.9 Microfracture in the Knee Study ...................................................................................... 148

10.10 Single- Versus Double-Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears 149

10.11 Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE) ....................................................................................................................... 149

10.12 Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty ................................................................................................................. 150

10.13 Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma ........................................... 151

10.14 Tibial Tunnel Widening in ACL Reconstruction-Comparing Two Bioscrews .................... 151

11 Current and Future Players ..................................................................................................... 152

11.1 Trends in Corporate Strategy .......................................................................................... 152

11.2 Company Profiles ............................................................................................................ 153

11.2.1 Arthrex ........................................................................................................................ 153

11.2.2 ArthroCare Corporation ............................................................................................... 155

11.2.3 Biomet ......................................................................................................................... 157

11.2.4 ConMed Corporation ................................................................................................... 160

11.2.5 DePuy Companies ...................................................................................................... 162

11.2.6 Smith & Nephew ......................................................................................................... 164

11.2.7 Stryker......................................................................................................................... 166

11.2.8 Tornier......................................................................................................................... 168

11.2.9 Wright Medical Group .................................................................................................. 171

11.2.10 Other Key Players in Sports Medicine ......................................................................... 174

12 Market Outlook ....................................................................................................................... 180

12.1 Company Market Share .................................................................................................. 180

12.1.1 Overview ..................................................................................................................... 180


Table of Contents


12.1.2 US ............................................................................................................................... 180

12.1.3 EU Market Share ......................................................................................................... 181

12.1.4 Asia-Pacific Market Share ........................................................................................... 184

12.1.5 South America Market Share ...................................................................................... 186

12.2 By Market Segment......................................................................................................... 187

12.2.1 Overview ..................................................................................................................... 187

12.2.2 Arthroscopy Implants ................................................................................................... 188

12.2.3 Arthroscopic Shavers .................................................................................................. 189

12.2.4 Arthroscopes ............................................................................................................... 190

12.2.5 Arthroscopic Radio Frequency Wands ........................................................................ 191

12.2.6 Arthroscopic Visualization Systems ............................................................................. 192

12.2.7 Arthroscopic Fluid Management Systems ................................................................... 193

12.3 By Geography ................................................................................................................. 195

12.3.1 Global Overview .......................................................................................................... 195

12.3.2 US ............................................................................................................................... 198

12.3.3 EU ............................................................................................................................... 201

12.3.4 Asia-Pacific ................................................................................................................. 212

12.3.5 South America............................................................................................................. 218

13 Appendix ................................................................................................................................. 221

13.1 Bibliography .................................................................................................................... 221

13.2 Abbreviations .................................................................................................................. 231

13.3 Research Methodology ................................................................................................... 236

13.3.1 Overview ..................................................................................................................... 236

13.3.2 Coverage .................................................................................................................... 236

13.3.3 Secondary Research ................................................................................................... 236

13.4 Physicians and Specialists Included in this Study ........................................................... 238

13.4.1 Dr. Henry D.E. Atkinson .............................................................................................. 238


Table of Contents


13.4.2 Dr. Joshua Alpert ........................................................................................................ 238

13.4.3 Dr. Andrea Ferretti....................................................................................................... 238

13.4.4 Dr. Alejandro Gonzalez Della Valle ............................................................................. 238

13.4.5 Dr. Andreas Imhoff ...................................................................................................... 238

13.4.6 Dr. Marcello Zaia Oliveira ............................................................................................ 238

13.4.7 Dr. Vidhya Ravi ........................................................................................................... 239

13.4.8 Dr. Elvire Servien ........................................................................................................ 239

13.4.9 Dr. Yotaro Yamakado .................................................................................................. 239

13.5 Primary Research ........................................................................................................... 240

13.5.1 Primary Research – Key Opinion Leader Interviews.................................................... 240

13.5.2 Primary Research – Physician and Industry Interviews ............................................... 240

13.5.3 Expert Panel Validation ............................................................................................... 241

13.6 Forecasting Methodology ................................................................................................ 241

13.7 About the Authors ........................................................................................................... 243

13.7.1 Analysts ...................................................................................................................... 243

13.7.2 Global Head of Healthcare .......................................................................................... 244

13.8 About MediPoint .............................................................................................................. 245

13.9 About GlobalData ............................................................................................................ 245

13.10 Disclaimer ....................................................................................................................... 245


Table of Contents


1.1 List of Tables

Table 1: Most Common Soft Tissue Injuries to the Extremities in Sports Medicine .......................................... 32

Table 2: Growth Rates for Arthroscopy by Joint in the US, 2013–2020 ........................................................... 38

Table 3: EU Growth Rate for Arthroscopy by Joint and Country, 2013–2020 .................................................. 40

Table 4: APAC Growth Rate for Arthroscopy by Joint and Country, 2013–2020.............................................. 42

Table 5: Brazil Growth Rate for Arthroscopy by Joint, 2013–2020 .................................................................. 43

Table 6: Medicare ICD-9 Diagnosis Codes for Common Sports Medicine Injuries, 2013 ................................. 46

Table 7: Medicare National Adjusted Reimbursement Rates for Common Sports Medicine Injuries for Hospital

Outpatient Treatment, 2013 ......................................................................................................... 47

Table 8: Medicare DRG Payments to Hospitals for Common Sports Medicine Injuries, 2013 .......................... 48

Table 9: Primary Differences Between FDA Approval and CE-Marking of Medical Devices ............................ 49

Table 10: Direct, Indirect, and Intangible Costs of Orthopedics ....................................................................... 71

Table 11: Potential Market for Meniscus Treatment Types ............................................................................. 75

Table 12: Metal Implant CharacteristicsThat Can Be Improved .................................................................... 101

Table 13: Arthrex Shoulder Implants ............................................................................................................ 112

Table 14: Arthrex, Shoulder Instrumentation ................................................................................................ 113

Table 15: Arthrex, Knee Sutures and Suture Anchors .................................................................................. 114

Table 16: Arthrex, Knee Graft Fixation Devices and Meniscal Products ........................................................ 115

Table 17: Arthrex, Hip Implants and Instruments .......................................................................................... 117

Table 18: Arthrex, Arthroscopy Procedure Capital Equipment ...................................................................... 118

Table 19: Arthrex, Implants SWOT Analysis ................................................................................................. 118

Table 20: Arthrex, Instrumentation SWOT Analysis ...................................................................................... 119

Table 21: Arthrocare, Suture Implants .......................................................................................................... 120

Table 22: ArthroCare, Suture Management Products ................................................................................... 121


Table of Contents


Table 23: ArthroCare, Cruciate Ligament Graft Fixation Products ................................................................. 122

Table 24: ArthroCare, Capital Equipment and Instruments ........................................................................... 122

Table 25: ArthroCare, Implants SWOT Analysis ........................................................................................... 123

Table 26: Arthrocare, Instruments and Capital Equipment SWOT Analysis .................................................. 123

Table 27: Biomet, Shoulder Arthroscopy Products ....................................................................................... 124

Table 28: Biomet, Knee Arthroscopy Products ............................................................................................. 126

Table 29: Biomet’s Other Joints Arthroscopy Products ................................................................................. 127

Table 30: Biomet, Capital Equipment Sports Medicine Products................................................................... 127

Table 31: Biomet Implants SWOT Analysis .................................................................................................. 128

Table 32: Biomet, Capital Equipment SWOT Analysis .................................................................................. 128

Table 33: ConMed, Shoulder Arthroscopy Products ..................................................................................... 129

Table 34: ConMed, Knee Arthroscopy Products ........................................................................................... 130

Table 35: ConMed, Small Joint and Hip Arthroscopy Products ..................................................................... 131

Table 36: ConMed, Instruments and Capital Equipment ............................................................................... 132

Table 37: ConMed, Implants SWOT Analysis ............................................................................................... 132

Table 38: ConMed, Capital Equipment SWOT Analysis ............................................................................... 133

Table 39: DePuy Mitek, Fixation Devices ..................................................................................................... 134

Table 40: DePuy, Mitek Instruments ............................................................................................................ 135

Table 41: DePuy Mitek, Capital Equipment .................................................................................................. 136

Table 42: DePuy Mitek Implants, SWOT Analysis ........................................................................................ 136

Table 43: DePuy Mitek, Capital Equipment SWOT Analysis ......................................................................... 136

Table 44: Smith & Nephew, Fixation Devices ............................................................................................... 137

Table 45: Smith & Nephew, Instruments and Capital Equipment .................................................................. 138

Table 46: Smith & Nephew Implants, SWOT Analysis .................................................................................. 139


Table of Contents


Table 47: Smith & Nephew, Capital Equipment SWOT Analysis ................................................................... 139

Table 48: Stryker, Fixation Devices .............................................................................................................. 140

Table 49: Stryker, Instrumentation ............................................................................................................... 140

Table 50: Stryker, Capital Equipment ........................................................................................................... 141

Table 51: Stryker, Fixation Devices SWOT Analysis .................................................................................... 141

Table 52: Stryker, Instrumentation and Capital Equipment SWOT Analysis .................................................. 141

Table 53: Tornier Sports Medicine Products ................................................................................................. 142

Table 54: Tornier, Product Family SWOT Analysis ....................................................................................... 142

Table 55: Can Shoulder Arthroscopy Work (CSAW) ..................................................................................... 145

Table 56: Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear ........................................... 146

Table 57: Knee Arthroscopy Cohort Southern Denmark ............................................................................... 146

Table 58: Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement ............... 147

Table 59: Femoroacetabular Impingement Randomized Controlled Trial ...................................................... 147

Table 60: Multicenter ACL Revision Study (MARS) ...................................................................................... 148

Table 61: Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability .................................... 148

Table 62: Results at 10 to 14 Years After Microfracture in the Knee ............................................................. 149

Table 63: Single Versus Double Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears ............ 149

Table 64: Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE)..... 150

Table 65: Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic

Acromioplasty ........................................................................................................................... 150

Table 66: Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma in Large to Massive Tears ................ 151

Table 67: Tibial Tunnel Widening in Anterior Cruciate Ligament Reconstruction Comparing Two Bioscrews. 151

Table 68: Company Profile – Arthrex ........................................................................................................... 154

Table 69: SWOT Analysis – Arthrex ............................................................................................................. 155

Table 70: Company Profile – ArthroCare Corporation .................................................................................. 156


Table of Contents


Table 71: SWOT Analysis – ArthroCare Corporation .................................................................................... 157

Table 72: Company Profile – Biomet ............................................................................................................ 158

Table 73: SWOT Analysis – Biomet ............................................................................................................. 159

Table 74: Company Profile – ConMed Corporation ...................................................................................... 161

Table 75: SWOT Analysis – ConMed Corporation ........................................................................................ 162

Table 76: Company Profile – DePuy Companies .......................................................................................... 163

Table 77: SWOT Analysis – DePuy Companies ........................................................................................... 164

Table 78: Company Profile – Smith & Nephew ............................................................................................. 165

Table 79: SWOT Analysis – Smith & Nephew .............................................................................................. 166

Table 80: Company Profile – Stryker ............................................................................................................ 167

Table 81: SWOT Analysis – Stryker ............................................................................................................. 168

Table 82: Company Profile – Tornier............................................................................................................ 169

Table 83: SWOT Analysis – Tornier ............................................................................................................. 170

Table 84: Company Profile – Wright Medical Group ..................................................................................... 172

Table 85: SWOT Analysis – Wright Medical Group ...................................................................................... 173

Table 86: Other Sports Medicine Companies in the US Market .................................................................... 174

Table 87: Other Sports Medicine Companies in the EU Market .................................................................... 175

Table 88: Other Sports Medicine Companies in the APAC Market................................................................ 177

Table 89: Global Sports Medicine Sales Forecast ($m), 2011–2020 ............................................................. 187

Table 90: Global Sports Medicine Sales Forecast ($m), Arthroscopy Implants, 2011–2020 .......................... 188

Table 91: Global Sports Medicine Sales Forecast ($m), Arthroscopic Shavers, 2011–2020 .......................... 189

Table 92: Global Sports Medicine Sales Forecast ($m), Arthroscopes, 2011–2020 ...................................... 190

Table 93: Global Sports Medicine Sales Forecast ($m), Arthroscopic RF Wands, 2011–2020 ...................... 192

Table 94: Global Sports Medicine Sales Forecast ($m), Arthroscopic Visualization Systems, 2011–2020 ..... 193


Table of Contents


Table 95: Global Sports Medicine Sales Forecast ($m), Arthroscopic Fluid Management Systems, 2011–2020

................................................................................................................................................. 194

Table 96: Global Sports Medicine Implant and Capital Equipment Sales ($m) Forecast by Country, 2011–2020

................................................................................................................................................. 196

Table 97: US Sports Medicine Sales Forecast ($m), 2011–2020 .................................................................. 200

Table 98: EU Sports Medicine Sales Forecast ($m), 2011–2020 .................................................................. 202

Table 99: France Sports Medicine Sales Forecast ($m), 2011–2020 ............................................................ 204

Table 100: Germany Sports Medicine Sales Forecast ($m), 2011–2020....................................................... 206

Table 101: Italy Sports Medicine Sales Forecast ($m), 2011–2020 .............................................................. 208

Table 102: Spain Sports Medicine Sales Forecast ($m), 2011–2020 ............................................................ 210

Table 103: UK Sports Medicine Sales Forecast ($m), 2011–2020 ................................................................ 211

Table 104: Japan Sports Medicine Sales Forecast ($m), 2011–2020 ........................................................... 213

Table 105: China Sports Medicine Sales Forecast ($m), 2011–2020 ............................................................ 215

Table 106: India Sports Medicine Sales Forecast ($m), 2011–2020 ............................................................. 217

Table 107: Brazil Sports Medicine Sales Forecast ($m), 2011–2020 ............................................................ 220

Table 108: Primary Research Interviews Completed in Sports Medicine ...................................................... 241


Table of Contents


1.2 List of Figures

Figure 1: Global Arthroscopic Procedure Volumes by Joint, 2011–2020 ......................................................... 36

Figure 2: US Arthroscopic Procedure Volumes, 2011–2020 ........................................................................... 37

Figure 3: US Arthroscopic Procedure Volumes by Joint, 2011–2020 .............................................................. 38

Figure 4: EU Arthroscopic Procedure Volumes, 2011–2020 ........................................................................... 39

Figure 5: EU Arthroscopic Procedure Volumes by Joint, 2011–2020 .............................................................. 40

Figure 6: APAC Region Arthroscopic Procedure Volumes, 2011–2020 .......................................................... 41

Figure 7: Brazil Arthroscopic Procedure Volumes, 2011–2020 ....................................................................... 42

Figure 8: Sources of Orthopedic Trauma (%) (n=103) .................................................................................... 93

Figure 9: US Market Share for Arthroscopy, 2012 ........................................................................................ 181

Figure 10: France Market Share for Arthroscopy, 2012 ................................................................................ 182

Figure 11: Germany Market Share for Arthroscopy, 2012 ............................................................................. 182

Figure 12: Italy Market Share for Arthroscopy, 2012 ..................................................................................... 183

Figure 13: Spain Market Share for Arthroscopy, 2012 .................................................................................. 183

Figure 14: UK Market Share for Arthroscopy, 2012 ...................................................................................... 184

Figure 15: Japan Market Share for Arthroscopy, 2012.................................................................................. 185

Figure 16: China Market Share for Arthroscopy, 2012 .................................................................................. 185

Figure 17: India Market Share for Arthroscopy, 2012 ................................................................................... 186

Figure 18: Brazil Market Share for Arthroscopy, 2012 .................................................................................. 186

Figure 19: Global Sports Medicine Sales Forecast ($m), 2011–2020............................................................ 188

Figure 20: Global Sports Medicine Sales Forecast ($m), Arthroscopy Implants, 2011–2020 ......................... 189

Figure 21: Global Sports Medicine Sales Forecast ($m), Arthroscopic Shavers, 2011–2020 ......................... 190

Figure 22: Global Sports Medicine Sales Forecast ($m), Arthroscopes, 2011–2020 ..................................... 191

Figure 23: Global Sports Medicine Sales Forecast ($m), Arthroscopic RF Wands, 2011–2020 ..................... 192


Table of Contents


Figure 24: Global Sports Medicine Sales Forecast ($m), Arthroscopic Visualization Systems, 2011–2020 .... 193

Figure 25: Global Sports Medicine Sales Forecast ($m), Arthroscopic Fluid Management Systems, 2011–2020

................................................................................................................................................. 194

Figure 26: Arthroscopy Implants Revenue by Major Market, 2013 and 2020................................................. 197

Figure 27: Arthroscopy Capital Equipment Revenue by Major Market, 2013 and 2020 ................................. 198

Figure 28: US Sports Medicine Sales Forecast ($m), 2011–2020 ................................................................. 200

Figure 29: EU Sports Medicine Sales Forecast ($m), 2011–2020 ................................................................. 202

Figure 30: France Sports Medicine Sales Forecast ($m), 2011–2020 ........................................................... 204

Figure 31: Germany Sports Medicine Sales Forecast ($m), 2011–2020 ....................................................... 207

Figure 32: Italy Sports Medicine Sales Forecast ($m), 2011–2020 ............................................................... 209

Figure 33: Spain Sports Medicine Sales Forecast ($m), 2011–2020 ............................................................. 210

Figure 34: UK Sports Medicine Sales Forecast ($m), 2011–2020 ................................................................. 212

Figure 35: Japan Sports Medicine Sales Forecast ($m), 2011–2020 ............................................................ 214

Figure 36: China Sports Medicine Sales Forecast ($m), 2011–2020............................................................. 216

Figure 37: India Sports Medicine Sales Forecast ($m), 2011–2020 .............................................................. 218

Figure 38: Brazil Sports Medicine Sales Forecast ($m), 2011–2020 ............................................................. 220



Introduction

2 Introduction

Sports injury is a very common occurrence in orthopedics that, depending on its severity, can be

treated either surgically or medically without any open intervention. It is also something that is not

limited to professional athletes, but is also seen in young children and teenagers and the elderly.

The aging population, as they keep to their recreational activities, are also more susceptible to

bone and tissue damage due to osteoarthritis. As the emerging markets are also experiencing

healthy growth in orthopedics, there is continued adoption of minimally-invasive technology.

The sports injury market still consists primarily of conservative treatments, such as nutritional

supplements, analgesics, corticosteroids, viscosupplementation and other medications. Based on

GlobalData’s key opinion leader (KOL) research, only XX% of sports injury patients go on to have

surgical intervention. And of those who are treated surgically, XX–XX% undergo outpatient

athroscopic procedures, as these surgeries do not require overnight stays. This minimally-invasive

technique saves significant healthcare costs and also continues to bring in revenue for hospitals

and practices, as several arthroscopic cases — as many as eight to nine — can be scheduled per

day, with one procedure lasting only XX minutes.

From a clinical standpoint, over the past 10 years, there have been many clinical studies validating

the effectiveness of various arthroscopic techniques. The early treatment methods focused more

on repair, and not on reconstruction. Anatomic single-bundle reconstruction of the ligaments versus

double-bundle reconstruction has been a point of contention, with debates on which has better

outcomes. Some of these techniques have been debated in conference forums, with regional

preferences (US versus EU) on ways to treat patients.

Biologics is another area that will rapidly change the face of sports orthopedics, particularly in the

US and EU markets. Tissue banks are used to prepare tissue for ligament reconstructions, which

are done arthroscopically. With the further development of better graft materials, GlobalData

expects procedural volume growth. Finally, bioabsorbable implants will continue to see

development, and as with the other orthopedics markets, physicians are looking for clinical data to

demonstrate the controlled bioresorbability of these materials to ensure timely healing in the natural

joints.

This report focuses on the sports medicine implant fixation market and capital equipment that is

commonly used across sports injury procedures. Implant fixation products include suture anchors,

Based on GlobalData’s key opinion leader (KOL) research, only 10% of sports injury patients go on to have surgical intervention.



Industry Overview

4.2.2 EU

Figure 4 illustrates the arthroscopic procedure volumes in the EU from 2011–2020. The market that

is most similar to the US in terms of the rise in the number of arthroscopic procedures and the

adoption of products is Germany. France follows Germany in terms of the number of arthroscopies

performed each year. As joint replacement growth rates begin to slow due to the austerity

measures implemented in Europe, the number of arthroscopic surgeries is set to rise.

Figure 4: EU Arthroscopic Procedure Volumes, 2011–2020

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

FranceGermanyItalySpainUK

Source: GlobalData

Figure 5 illustrates the procedure volumes for the individual joints’ arthroscopy markets in the EU

from 2011–2020. Knee arthroscopies are the most commonly performed procedures in the EU,

with shoulder being second. The shoulder market, while seeing steady growth, is not growing at the

dramatic rate as seen in the US market. The hip segment, despite its currently low numbers, is the

area to watch, with new products and indications driving its growth. The volumes are still very low

in hip arthroscopy which is the reason for high growth rates in the EU countries as adoption picks

up.

The hip segment, despite its currently low numbers, is the area to watch, with new products and indications driving its growth.


Market Outlook


12.2 By Market Segment

12.2.1 Overview

According to GlobalData’s estimates, in 2013, the arthroscopic implants market was valued at $XX

billion, and the remaining capital equipment market was valued at $XX billion, amounting to a total

market value of $XX billion. By the end of the forecast period in 2020, these markets are expected

to be valued at $XX billion and $XX billion, respectively, totalling $XX billion. The implants segment

will grow at a CAGR of XX% during the forecast period, and will be the only segment of capital

equipment that is rising. The RF wands segment will grow the fastest, at a CAGR of XX%, with

shavers and arthroscopes following at CAGRs of XX% and XX%, respectively. The remaining

segments will grow at a much lower rate, signifying that fluid management and visualization

systems are of less importance.

Table 89 and Figure 19 present the global sports medicine sales forecast during 2011–2020.

Table 89: Global Sports Medicine Sales Forecast ($m), 2011–2020

Year 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 CAGR (%)

Arthroscopic Implants

Shavers

Arthroscopes

RF Wands

Visualization Systems

Fluid Management Systems

Total Sales Source: GlobalData


Market Outlook


Figure 19: Global Sports Medicine Sales Forecast ($m), 2011–2020

2011 2012 2013 2014 2015 2016 2017 2018 2019 2020Year

Arthroscopic Implants Arthroscopic ShaversArthroscopes Arthroscopic RF WandsArthroscopic Visualization Systems Arthroscopic Fluid Management Systems

Source: GlobalData

12.2.2 Arthroscopy Implants

With the rapid growth in arthroscopic surgical intervention, as opposed to open surgery,

arthroscopic implants will see rapid growth during the forecast period, with a CAGR of XX%. These

implants are most often used in the shoulder and knee, and are now also increasingly being

implanted in the small joints and hip. According to GlobalData’s estimates, the global arthroscopic

implants market was worth $XX billion in 2013, and will rise to $XX billion in 2020, at a CAGR of

XX%.

Table 90 and Figure 20 present the global sports medicine sales forecast for arthroscopy implants

during 2011–2020.

Table 90: Global Sports Medicine Sales Forecast ($m), Arthroscopy Implants, 2011–2020

Year 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 CAGR (%)

Arthroscopy Implants

Source: GlobalData

With the rapid growth in arthroscopic surgical intervention, as opposed to open surgery, arthroscopic implants will see rapid growth during the forecast period, with a CAGR of XX%.


Appendix


13 Appendix

13.1 Bibliography

AAOS (2010). Helping Fractures Heal (Orthobiologics). Available from:

http://orthoinfo.aaos.org/topic.cfm?topic=A00525. [Accessed September 29, 2013.]

Academy for International Health Studies (AIHS) (2008). Report on the Health System of India.

Available from: http://www.tpg-iha.com/pdf/AIHSIndiaReportFinal.pdf. [Accessed October 11,

2013].

Adams SB, Jr., et al. (2005). Tissue engineering for meniscus repair. Journal of Knee Surgery;

18(1): 25–30.

Aetna (2014). Clinical Policy Bulletin: Menaflex. Number 0786. Available from:

http://www.aetna.com/cpb/medical/data/700_799/0786.html. [Accessed January 21, 2014].

American Academy of Orthopaedic Surgeons (AAOS) (2007). Arthritis of the knee. Available

from: http://orthoinfo.aaos.org/topic.cfm?topic=a00212. [Accessed June 24, 2013].

American Academy of Orthopaedic Surgeons (AAOS) (2012). Elbow Injuries in the Throwing

Athlete. Available from: http://orthoinfo.aaos.org/topic.cfm?topic=A00644. [Accessed January

6, 2014].

Al-Obaid YF and Bangash FN (2007). Trauma – An Engineering Analysis. Google Ebook.

Available from:

http://books.google.com/books?id=JgZaSUYHTjYC&dq=composite+materials+trauma&source

=gbs_navlinks_s. [Accessed September 29, 2013.]

American Academy of Orthopaedic Surgeons (AAOS) (2013). Viscosupplementation treatment

for arthritis. Available from: http://orthoinfo.aaos.org/topic.cfm?topic=a00217. [Accessed June

24, 2013].

Arthrex (2014). Product and Technical Information. Available from: http://www.arthrex.com/.

[Accessed January 22, 2014].

ArthroCare Corporation (2014). Product and Technical Information. Available from:

http://www.arthrocaresportsmedicine.com/products. [Accessed January 23, 2014].


Appendix


Barry P (2008). Medical Device Reimbursement in Japan. Massmedic Presentation, Boston

Scientific Corporation. Available from: http://www.scribd.com/doc/61860687/Japan-Medical-

Device-Reimbursement-Policy. [Accessed December 28, 2012].

Bennell KL, et al. (2012). Management of osteoarthritis of the knee. BMJ Clinical Review; 345:

e4934.

Bergen Orthopedic Study Group, Results at 10 to 14 Years After Microfracture in the Knee,

NCT01747681. Available from: http://www.clinicaltrials.gov/ct2/show/NCT01747681. [Accessed

February 2, 2014].

Bermejo M (2012). Southern American approach to the regulation of medical devices – Current

situation in Chile and other MERCOSUR countries. Available from:

http://www.tuftad.org.tr/folders/M_Bermejo.pdf. [Accessed June 13, 2013].

Biomet (2013). 10K ending May 31, 2013. Available from:

http://www.biomet.com/fileLibrary/corporate/investors/financials/May31201310k.pdf. [Accessed

on November 18, 2013].

Biomet (2014). Product and Technical Information. Available from:

http://www.biomet.com/sportsMedicine/. [Accessed January 23, 2014].

Borgonovi E, et al. (2009). European Health Technology Institute for Socio-Economic

Research. Centre for Research on Health and Social Care Management - CERGAS, Universita

Bocconi. Available from:

http://s3.amazonaws.com/zanran_storage/www.together4healthinnovation.eu/ContentPages/4

3174550.pdf. [Accessed September 27, 2012].

Botser IB, et al. (2011). Open surgical dislocation versus arthroscopy for femoroacetabular

impingement: a comparison of clinical outcomes. Arthroscopy; 27(2): 270–278.

Brazilian Health Agency, ANVISA (2009). HTA and the Decision-Making Process: the role of

the Brazilian Health Agency (ANVISA). Available from:

http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=6&ved=0CFEQFjAF&url=

http%3A%2F%2Fwww.observatorysummerschool.org%2Fforce.php%3Ffile%3Darchivio%2F1

01%2FALemgruber.pdf&ei=ZFHkUM29Ce-

n0AGW5IGgBg&usg=AFQjCNFPfZSVbggFgULK78zglL7AfIW2yA&bvm=bv.1355534169,d.dm

Q&cad=rja. [Accessed January 2, 2013.]


Appendix


Centers for Disease Control and Prevention (CDC) (2009). Healthy aging – Improving and

extending quality of life among older Americans. Available from:

www.cdc.gov/nccdphp/publications/aag/pdf/healthy_aging.pdf . [Accessed June 20, 2013].

Centers for Disease Control and Prevention (CDC) (2013). A National Action Plan for Child

Injury Prevention: Reducing Sports and Recreation-Related Injuries in Children. Available from:

http://www.cdc.gov/safechild/NAP/overviews/sports.html. [Accessed January 26, 2014].

Chen A, et al. (2012). The global economic cost of osteoarthritis: how the UK compares.

Arthritis; Epub October 2, 2012 (1–6).

Cheng SWK (2010). Endovascular Practice in Asia-Pacific. In: Fogarty TJ and White RJ.

Peripheral Endovascular Interventions, 3rd ed. Springer, New York, NY.

ClinSearch (2011). Marketing Medical Devices in France. Available from:

http://www.clinsearch.net/dev/meddev_france.html. [Accessed September 21, 2013].

Colvin AC, et al. (2012). Trends in hip arthroscopy. The Journal of Bone and Joint Surgery;

94(4): e23(1–5).

ConMed Corporation (2014). Product and Technical Information. Available from:

http://www.conmed.com/products/arthroscopy.php. [Accessed January 23, 2014].

Covidien (2013). 2013 Sports Surgery: Medicare Reimbursement Coding Guide. Available

from:

http://www.covidien.com/imageServer.aspx/doc267039.29.13%20FINAL.pdf?contentID=37143

&contenttype=application/pdf. [Accessed February 3, 2014].

Cummings CA and Murrell GA (2003). Mode of failure for rotator cuff repair with suture anchors

identified at revision surgery. Journal of Shoulder and Elbow Surgery; 12(2): 128–133.

Deng C, et al. (2012). Tales of Three Medical Device Markets in China. Available from:

http://www.navigant.com/~/media/WWW/Site/Insights/Healthcare/China%20Medical%20Device

s%20Market_Navigant_2012.ashx. [Accessed March 22, 2013].

DePuy Mitkek (2014). Product and Technical Information. Available from:

http://www.depuy.com/healthcare-

professionals/products?#Search%3Fspecialty%3D0%26category%3D0%26focus%3D0%26fa

mily%3D0%26keyword%3D%26company%3D248. [Accessed January 26, 2014].


Appendix


Diab MA, at al. (2009). Time and cost savings in arthroscopic subacromial decompression: the

use of bipolar versus monopolar radiofrequency. International Orthopaedics. 33(1): 175–179.

Economist Intelligence Unit (2010). Broadening Healthcare Access in Brazil Through

Innovation. Available from:

http://www.managementthinking.eiu.com/sites/default/files/Roche_Healthcare_WEB_English.p

df. [Accessed January 2, 2013.]

Emergo Group (2013). Medical Device Consulting Services by Country/Region. Available from:

http://www.emergogroup.com/services. [Accessed October 11, 2012.]

Fetzer GB, et al. (2009). Potential market for new meniscus repair strategies: evaluation of the

MOON cohort. Journal of Knee Surgery; 21: 180–186.

Fong DT, et al. (2009). Understanding acute ankle ligamentous sprain injury in sports. Sports

Medicine, Arthroscopy, Rehabilitation, Therapy & Technology; 1: 14.

Food and Drug Administration (FDA) (2012). Unsafe and Ineffective Devices Approved in the

EU that were Not Approved in the US. Available from:

http://www.elsevierbi.com/~/media/Supporting%20Documents/The%20Gray%20Sheet/38/20/F

DA_EU_Devices_Report.pdf. [Accessed January 9, 2013].

George B (2010). Registration of medical devices. Perspectives in Clinical Research; 1(3): 90–

93.

George MS and Khazzam M (2012). Current concepts review: revision rotator cuff repair.

Journal of Shoulder and Elbow Surgery; 21: 431–440.

Ghodadra NS, et al., (2009). Open, mini-open, and all-Arthroscopic rotator cuff repair surgery:

indications and implications for rehabilitation. Journal of Orthopaedic and Sports Physical

Therapy; 39(2): 80–89.

GlobalData (2010). Brazil Medical Equipment Market Profile [MECUP1630]. [Accessed

September 10, 2013].

Gross A (2007). Medical Device Market Opportunities in India. Pacific Bridge Medical - India

Medical Publications. Available from: http://www.sona-

enterprise.com/PdfFiles/MedicalDeviceMarketOpportunitiesinIndia.pdf. [Accessed February 23,

2013].


Appendix


Growing Athletes (2012). Growing Athletes: Hip Arthroscopy. Available from:

http://www.growingathletes.ca/?page_id=93. [Accessed January 14, 2014].

Haviv B, et al. (2011). Trends in femoroacetabular impingement research over 11 years.

Orthopedics; 34(5): 353.

Huijsmans PE, et al. (2007). Arthroscopic rotator cuff repair with double-row fixation. Journal of

Bone and Joint Surgery; 89(6): 1248–1257.

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (2012). Italy –

Medical Devices and Diagnostics. Available from:

http://www.ispor.org/htaroadmaps/italy/italy_mdd.asp. [Accessed December 31, 2012].

International Trade Administration (ITA) (2007). Medical Device Reimbursement in China.

Available from:

http://ita.doc.gov/td/health/Medical%20Reimbursement%20in%20China%202007.pdf.


International Trade Administration (ITA) (2012). Medical Device Regulatory Requirements for

Brazil. Available from: http://ita.doc.gov/td/health/brazilmdprofile.pdf. [Accessed September 24,

2012].

Jommi C, et al. (2001). New funding arrangements in the Italian National Health Service.

International Journal of Health Planning and Management; 16(4): 347–368.

Kaul U and Bhatia V (2010). Perspective on coronary interventions and cardiac surgeries in

India. Indian Journal of Medical Research; 132: 543–548.

Kaushik A, et al. (2010). Harmonized medical device regulation: need, challenges, and risks of

not harmonizing the regulation in Asia. Journal of Young Pharmacists; 2(1): 101–106.

Lex Mundi (2011). Medical Devices: A Global Practice Guide. Available from:

http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=9&cad=rja&ved=0CGIQFj

AI&url=http%3A%2F%2Fwww.lexmundi.com%2FDocument.asp%3FDocID%3D3404&ei=5E7k

UNreM6a50AGe9oHgDw&usg=AFQjCNHo7DE2PxDtYCAQ47OW1jJdAYSbLQ&bvm=bv.1355

534169,d.dmQ. [Accessed January 2, 2013].

Lotter O, et al. (2012). Diagnosis-related groups in hand surgery--a comparison of six

European countries. German Medical Science; Epub April 24, 2012.


Appendix


Matassi F, et al. (2013). Porous metal for orthopedics implants. Clinical Cases in Mineral and

Bone Metabolism. 10(2):111–115.

McCarty LP and Cole BJ (2005). Nonarthroplasty treatment of glenohumeral cartilage lesions.

Arthroscopy; 21(9): 1131–1142.

McMaster University, Femoroacetabular Impingement Randomized Controlled Trial (FIRST),

NCT01623843. Available from: http://clinicaltrials.gov/ct2/show/NCT01623843. [Accessed

February 2, 2014].

Medical Devices Today (2010). Medicare Inpatient Proposal: No Near-Term Trouble Spots For

Device Sector. Available from: http://www.medicaldevicestoday.com/2010/04/medicare-

inpatient-proposal-no-nearterm-trouble-spots-for-device-sector-.html#more. [Accessed

December 20, 2012].

Mediclever (2010). A Shortcut to Medical Device Reimbursement in Germany. Available from:

http://mediclever.com/blog/?p=43. [Accessed December 30, 2012].

Ministry of Health of Brazil (2008). Health Technology Assessment. Available from:

http://200.214.130.94/rebrats/publicacoes/ATS_INGLES.pdf. [Accessed January 2, 2013].

Morgan Lewis (2008). Medical Reimbursement for Drugs and Devices. In: Emerging Life

Sciences Companies Deskbook, 2nd ed. Available from:

http://www.morganlewis.com/documents/erh/ERH_MedicareReimbursementForDrugsAndDevi

ces_ELSCDeskbook.pdf. [Accessed September 25, 2012].

Nagasaka S, et al. (2008). An Overview of Pharmaceutical and Medical Device Regulation in

Japan. Available from: http://www.morganlewis.com/pubs/Overview_Pharma_device_reg.pdf.

[Accessed February 22, 2013].

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (2013). Handout

on Health: Sports Injuries. Available from:

http://www.niams.nih.gov/Health_Info/Sports_Injuries. [Accessed January 3, 2014].

New York-Presbyterian (2014). Orthopedic Surgery and Trauma Service: Sports and Soft

Tissue Trauma. Available from: http://nyp.org/services/orthopedic-surgery/weill-cornell/sports-

soft-tissue.html. [Accessed on January 6, 2014].


Appendix


Onze Lieve Vrouwe Gasthuis, Early Surgery Versus Conservative Therapy for Meniscal

Injuries in Older Patients (ESCAPE), NCT01850719. Available from:

http://clinicaltrials.gov/ct2/show/NCT01850719. [Accessed February 2, 2014].

Pacific Bridge Medical, India Medical Publications (2007). Medical Device Market Opportunities

in India. Available from: http://www.sona-

enterprise.com/PdfFiles/MedicalDeviceMarketOpportunitiesinIndia.pdf. [Accessed January 3,

2013.]

Panam Clinic, Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without

Arthroscopic Acromioplasty, NCT00290888. Available from:


Panam Clinic, Tibial Tunnel Widening in Anterior Cruciate Ligament (ACL) Reconstruction-

Comparing Two Bioscrews, NCT01727739. Available from:

http://www.clinicaltrials.gov/ct2/show/NCT01727739. [Accessed February 2, 2014].

Perriello B (2013a). Judge orders arthrex to halt some suture anchor sales. Mass Device.

Available from: http://www.massdevice.com/news/judge-orders-arthrex-halt-some-suture-

anchor-sales?page=3. [Accessed January 6, 2013].

Perriello B (2013b). KFx Medical lands a pair of wins in patent suit against Arthrex. Mass

Device. Available from: http://www.massdevice.com/news/kfx-medical-lands-pair-wins-patent-

suit-against-arthrex. [Accessed January 6, 2013].

Popov G, et. al. (2003). Radiation Processing of Composites for Orthopaedic Implants.

Proceedings of the 2003 Particle Accelerator Conference.

Powell AC (2012). Chinese and American Healthcare Systems: A Comparison 360º Analysis.

Fair Observer. Available from: http://www.fairobserver.com/article/chinese-and-american-

healthcare-systems-comparison. [Accessed January 2, 2013].

Quotec Ltd. (2010). Commercialising Medical Devices: A Guide for UK Based Small

Companies. Available from:

http://www.quotec.co.uk/attachments/article/37/Commercialising%20Medical%20Devices.pdf.

[Accessed December 26, 2012].


Appendix


Richards DP and Burkhart SS (2007). Arthroscopic debridement and capsular release for

glenohumeral osteoarthritis. Arthroscopy; 23(9): 1019–1022.

Rodrigues J (1989). Hospital utilization and reimbursement methods in Brazil. International

Journal of Health Planning and Management; 4(1): 3–15.

Rothman Institute (2014). Hip Arthroscopy. Available from:

http://www.rothmaninstitute.com/specialties/treatments/hip-arthroscopy. [Accessed January 14,

2013].

Ryan J and Cohen DJ (2006). Are drug-eluting stents cost-effective? It depends on whom you

ask. Circulation; 114:1736–1744.

Sampson TG (2011). Arthroscopic treatment for chondral lesions of the hip. Clinical Sports

Medicine; 31: 331–348.

Samsung Medical Center, Single Versus Double Row Suture Anchor Repair in Medium to

Large Rotator Cuff Tears, NCT01039571. Available from:


Schreyogg J, et al. (2009). Balancing adoption and affordability of medical devices in Europe.

Health Policy; 92: 218–224.

Seligson D, et al. (2012). External fixation in economically disadvantaged areas. In: Seligson

D, et al., eds. External Fixation in Orthopedic Traumatology. Springer-Verlag London Limited,

London, England.

Seoul National University Hospital, Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma

(PRP) in Large to Massive Tears. Available from:


Sihvonen R, et al. (2013). Arthroscopic partial meniscectomy versus sham surgery for a

degenerative meniscal tear. New England Journal of Medicine.; 369: 2515–2524.

Smith & Nephew (2014). Product and Technical Information. Available from: http://www.smith-

nephew.com/professional/products/sports-medicine/. [Accessed January 25, 2014].

Steinmann J, et al. (2009). Surgeon Ownership in Medical Device Distribution: Economic

Analysis of an Existing Model, Annual Meeting 2009. American Academy of Orthopaedic


Appendix


Surgeons, Scientific Exhibit SE48. Available from:

http://www.hoganlovells.com/files/upload/Feb2009_SurgeonOwnershipDevices.pdf. [Accessed

January 24, 2013].

Stryker (2014). Product and Technical Information. Available from: http://www.stryker.com/en-

us/products/Orthopaedics/SportsMedicine/index.htm. [Accessed January 25, 2014].

Tannast M, at al. (2007). Femoroacetabular impingement: Radiographic diagnosis--what the

radiologist should know. American Journal of Roentgenology. 188(6): 1540–1552.

The Commonwealth Fund (2011). International Profiles of Health Care Systems, 2011.

Available from:

http://www.commonwealthfund.org/~/media/Files/Publications/Fund%20Report/2011/Nov/1562

_Squires_Intl_Profiles_2011_11_10.pdf. [Accessed December 28, 2012].

Tornier B.V. (2010). US SEC Filing. Available from:

http://www.sec.gov/Archives/edgar/data/1492658/000104746910005811/a2199037zs-

1.htm#bg72301a_main_toc. [Accessed January 7, 2013].

Tornier B.V. (2014). Product and Technical Information. Available from: http://www.tornier-

us.com/sportsmed/. [Accessed January 25, 2014].

Tornier N.V. (2013). US SEC Filing. Available from:

http://investor.tornier.com/secfiling.cfm?filingID=1193125-13-87359&CIK=1492658. [Accessed

August 27, 2013].

TUV SUD (2013). Medical Technology in Brazil. E-ssentials. Available from: http://www.tuev-

sued.de/uploads/images/1365058506989160031101/e-ssentials-tuev-sued-medicaldevices-en-

volume1-march2013.pdf. [Accessed September 4, 2013].

UC Davis Health System (2010). Chinese national sports team physicians seek UC Davis

expertise. Available from:

http://www.ucdmc.ucdavis.edu/welcome/features/20100609_Chinese_visit/index.html.


University of Calgary, Arthroscopic Versus Open Stabilization for Traumatic Shoulder

Instability, NCT00251264. Available from: http://clinicaltrials.gov/ct2/show/NCT00251264.

[Accessed February 2, 2014].


Appendix


University of California, San Francisco (UCSF) (2011). Sports Medicine: Knee. University of

California, San Francisco, Department of Orthopaedic Surgery, Orthopaedic Trauma Institute.

Available from: http://orthosurg.ucsf.edu/oti/patient-care/divisions/sports-

medicine/conditions/knee/cartilage-injury/. [Accessed January 21, 2014].

University of Oxford, Can Shoulder Arthroscopy Work (CSAW), NCT01623011. Available from:

http://clinicaltrials.gov/show/NCT01623011. [Accessed February 2, 2014].

University of Southern Denmark, Knee Arthroscopy Cohort Southern Denmark (KACS),

NCT01871272. Available from: http://clinicaltrials.gov/ct2/show/NCT01871272. [Accessed

February 2, 2014].

University of Tampere, Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear,

NCT00549172. Available from: http://clinicaltrials.gov/show/NCT00549172. [Accessed

February 2, 2014].

University of Western Ontario, Canada, Hip Arthroscopy Versus Conservative Management of

Femoroacetabular Impingement, NCT01621360. Available from:


Vanderbilt University, Multicenter ACL Revision Study (MARS), NCT00625885. Available from:


Wheeless’ Textbook of Orthopedics (2013). Characteristics of Metals and Implants. Available

from: http://www.wheelessonline.com/ortho/characteristics_of_metals_and_implants.

[Accessed on January 16, 2014].


Appendix


13.2 Abbreviations

10MM 10 major markets (US, France, Germany, Italy, Spain, UK, Brazil, China, India,

South America)

AAOS American Association of Orthopaedic Surgeons

ABOS American Board of Orthopaedic Surgery

ACA Affordable Care Act

ACL anterior cruciate ligament

AIHS Academy for International Health Studies

ANVIS Agência Nacional de Vigilância Sanitária

AOSS American Orthopaedic Society for Sports Medicine

APC Ambulatory Payment Classification

BGMP Brazilian Good Manufacturing Practice

CAGR Compound Annual Growth Rate

CDCSO Central Drugs Standard Control Organization

CDC Centers for Disease Control and Prevention

CE Conformité Européenne

CFDA China Food and Drug Administration

CDCSO Central Drugs Standard Control Organization

CITEC Centro de Inovação Tecnológica em Cerâmica

CLAA Central License Approval Authority

CMF craniomaxillofacial

CMOS complementary metal oxide semiconductor

CMS Centers for Medicare & Medicaid Services

CO2 carbon dioxide

CoCr cobalt-chromium


Appendix


CONITEC National Commission for Incorporation of Technologies in the Unified Healthcare

System

CPT Current Procedural Terminology

CSAW Can Shoulder Arthroscopy Work study

CT computed tomography

dGEMRIC delayed gadolinium-enhanced MRO of cartilage

DPC Diagnosis Procedure Combination

DRG Diagnosis-Related Group

EC European Commission

ECG electrocardiography

ECRI Emergency Care Research Institute

EMS electrical muscle stimulation

ENT ear, nose, and throat

FAI femoroacetabular impingement

FDA Food and Drug Administration

GDP Gross Domestic Product

G-DRG German Diagnosis-Related Group

GMP Good Manufacturing Practice

HA hydroxy apatite

HD high-definition

HRG Healthcare Resource Group

HTA Health Technology Assessments

HTAC Health Technology Assessment Committee

HSS Hospital for Special Surgery

ICAC Indian Conformity Assessment Certificate


Appendix


ICD-9 International Classification of Diseases, Ninth Revision

IM intramedullary

IMDRA Indian Medical Devices Regulatory Authority

INMETRO Instituto Nacional de Metrologia, Normalizacao e Qualidade Industrial

ISO International Organization for Standardization

ISPOR International Society for Pharmacoeconomics and Outcomes Research

ITA International Trade Administration

J&J Johnson & Johnson

KOL key opinion leader

LCL lateral collateral ligament

LED light-emitting diode

LHU Local Health Units

LSE London Stock Exchange

M&A merger and acquisition

MARS Multicenter ACL Revision Study

MCL medial collateral ligament

MERCOSUR Mercado Común del Sur

MHLW Ministry of Health, Labour and Welfare

MOH Ministry of Health

MTF Musculoskeletal Transplant Foundation

N Newtons

NASDAQ National Association of Securities Dealers Automated Quotations

NDRC National Development and Reform Commission

NHS National Health Service


Appendix


NIAMS National Institute of Arthritis and Musculoskeletal and Skin Diseases

NICE National Institute for Health and Care Excellence

NSAID non-steroidal anti-inflammatory drug

NUB New Diagnostic and Treatment Method

NYSE New York Stock Exchange

OB/GYN obstetrics and gynecology

OMS National Health Agency

ORIF open reduction and internal fixation

OTC over the counter

PCL Posterior Cruciate Ligament

PCP primary care physician

PEEK polyether ether ketone

PGA polyglycolic acid

PLDLA poly-L/D-lactide

PLLA poly-L-lactic acid

PMA Premarket Approval

PMDA Pharmaceutical and Medical Devices Agency

PVS polyvinyl siloxane

PRP platelet-rich plasma

R&D research and development

RF radiofrequency

SD standard-definition

SEC Securities and Exchange Commission

SET sports, extremities, trauma


Appendix


SHI Statutory Health Insurance

SSN Servizio Sanitario Nazionale

SUS Sistema Único de Saúde

SWOT strengths, weaknesses, opportunities, threats

TCM Traditional Chinese Medicine

TCP beta tricalcium phosphate

Ti titanium

UCL ulnar collateral ligament

UHMWPE ultra-high-molecular-weight polyethylene

USCF University of California, San Francisco

VEO valgus extension overload

VHI Voluntary Health Insurance


Appendix


13.3 Research Methodology

13.3.1 Overview

GlobalData’s dedicated research and analysis teams consist of experienced professionals with

extensive experience in marketing and market research, consulting backgrounds in the medical

device industry, and advanced statistical expertise.

GlobalData adheres to the Codes of Practice of the Market Research Society (www.mrs.org.uk)

and the Strategic and Competitive Intelligence Professionals (www.scip.org). All GlobalData

databases are continuously updated and revised. The following research methodology is followed

for all databases and reports.

13.3.2 Coverage

GlobalData’s coverage is designed to ensure that it represents the most up-to-date vision of the

industry possible. Changes to industry taxonomy are based on extensive research of companies,

associations, and competitors. Company coverage is based on three key factors: revenues,

products, and media attention/innovation/market potential.

The estimated revenues of all major companies, including private and governmental, are

gathered and used to prioritize coverage.

Companies that are making the news, or that are of particular interest due to their innovative

approach, are prioritized.

GlobalData aims to provide coverage on all major news events and deals in the medical device

industry, updated on a daily basis. The coverage is further streamlined and strengthened with

additional input from GlobalData’s panel of experts (see below).

13.3.3 Secondary Research

The research process begins with exhaustive secondary research into internal and external

sources to gather qualitative and quantitative information relating to each market.

The secondary research sources that are typically referred to include, but are not limited to:

Reports and databases published by national and international agencies, such as the

American Academy of Orthopaedic Surgeons, International Trade Administration, Orthopaedic

Trauma Association, Orthopedic News Network ,and World Health Organization.


Appendix


National government documents and databases from the Centers for Disease Control and

Prevention, Centers for Medicare & Medicaid Services, US Food and Drug Administration,

National Institute for Health and Care Excellence, and National Health Service. Population

figures were attained through the US Census Bureau database.

Scientific journals, such as Journal of Bone and Joint Surgery, The Burden of Musculoskeletal

Diseases in the United States, Open Orthopaedic Journal, and other technical literature.

Company websites, annual reports, financial reports, investor presentations, and SEC filings.

Relevant regulatory and device approval databases, such as the FDA 510(k) and Premarket

Approval databases.

News articles, press releases, and webcasts relating to companies operating in the market.


Appendix


13.4 Physicians and Specialists Included in this Study

13.4.1 Dr. Henry D.E. Atkinson

Orthopedic Surgeon

Department of Trauma and Orthopaedics and North London Sports Orthopaedics

North Middlesex University Hospital, London, UK

13.4.2 Dr. Joshua Alpert

Orthopedic Surgeon

Midwest Bone and Joint Institute, Chicago Suburbs, Illinois, US

13.4.3 Dr. Andrea Ferretti

Professor and Chairman of Orthpaedics

Department of Orthopaedics and Traumatology, Kirk Kilgour Sports Injury Center

Sant’ Andrea Hospital

Sapienza University of Rome, Rome, Italy

13.4.4 Dr. Alejandro Gonzalez Della Valle

Associate Attending Orthopedic Surgeon, Hospital for Special Surgery

Associate Professor of Orthopedic Surgery, Weill Cornell Medical College, NY, US

13.4.5 Dr. Andreas Imhoff

Professor

Sports Orthopaedics Department and Clinic, Rechts der Isar Hospital

Technical University of Munich, Munich, Germany

13.4.6 Dr. Marcello Zaia Oliveira

Orthopedic Surgeon

Hospital Universitario do Parana


Appendix


13.4.7 Dr. Vidhya Ravi

Orthopedic Surgeon

Maruti Hospital, Tiruchirappalli, Tamil Nadu, India

13.4.8 Dr. Elvire Servien

Professor of Department of Orthopaedic Surgery

Centre Albert Trillat, Groupe Hospitalier Nord, Hospices Civils de Lyon, France

13.4.9 Dr. Yotaro Yamakado

Orthopedic Surgeon

Department of Sports Medicine and Orthopaedics, Fukui General Hospital, Fukui, Japan


Appendix


13.5 Primary Research

13.5.1 Primary Research – Key Opinion Leader Interviews

GlobalData conducts hundreds of primary interviews a year with industry participants and

commentators in order to validate its data and analysis. A typical research interview fulfills the

following functions:

Provides first-hand information on factors such as market size, market trends, growth trends,

competitive landscape, and future outlook

Helps in validating and strengthening the secondary research findings.

Further develops the analysis team’s expertise and market understanding.

Primary research involves e-mail interactions and telephone interviews for each market,

category, segment, and sub-segment across different geographies.

The participants who typically take part in interviews include, but are not limited to:

Key opinion leaders (KOLs): Trauma and sports orthopedic surgeons who specialize in treating

patients with sports injuries. Some of the surgeons are also often extremity specialists.

Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers,

and national sales managers.

13.5.2 Primary Research – Physician and Industry Interviews

A total of 224 interviews with orthopedic surgeons and the supply side (companies and distributors)

have been completed for the markets included in this report. The physicians targeted for these

interviews are orthopedic surgeons with a subspecialty in sports medicine. And the supply side

interviews consisted of product managers, marketing professionals, sales professionals, and other

industry participants from the sports medicine market. The interviews involved contributed in

validating market forecast, unmet needs and other trends in the sports medicine market. Table 108

provides a complete breakdown of the primary research interview participants in this study.


Appendix


Table 108: Primary Research Interviews Completed in Sports Medicine

Arthroscopy Unique Model Overall

Physicians Companies/Distributors Overall

Arthroscopy Implants 23 19 42

Arthroscopic Shavers 22 14 36

Arthroscopes 20 16 36

Arthroscopy Fluid Management Systems 12 20 32

Arthroscopy Visualization Systems 15 25 40

Arthroscopy Radiofrequency Systems 23 15 38

Total Count 115 109 224 Source: GlobalData

13.5.3 Expert Panel Validation

GlobalData uses a panel of experts to cross-verify its databases and forecasts. GlobalData’s expert

panel consists of marketing managers, product specialists, international sales managers from

medical device companies, academics from research universities, KOLs from hospitals,

consultants from venture capital funds, and distributors/suppliers of pharmaceuticals and related

supplies. Historic data and forecasts undergo scrutiny from GlobalData’s expert panel and are

adjusted in accordance with their feedback.

13.6 Forecasting Methodology

GlobalData uses a patient-based forecasting model to determine the market size for therapeutic

indications. Estimates are based on a number of sources, including primary research – KOL

interviews and physician surveys – and secondary research, such as company reports, press

releases, published articles, proprietary databases, and general news media. The base year and

the forecast years of the model are grounded in the market parameters listed below.

Procedural Data

The total number of arthroscopic procedures in the primary joints of interest were estimated and

forecast across the 10 markets. This procedural data was validated by both physician and industry

input through interviews. The procedure population represents the total number of cases during a

given year. The procedural numbers were obtained through medical literature, government

sources, disease foundations, and other recently published GlobalData reports.


Appendix


Product Volume Sales

Once the procedure volume in a given country is established, GlobalData’s analysts carve out the

portion of that population that receives fixation devices and then determines the number of implants

per procedure. Likewise, for all the capital equipment forecast, the number of procedures done per

equipment was estimated from interviews, and the market value was determined using the average

selling price from the primary and secondary sources listed above.

Average selling price (ASP)

The average selling price of the products for arthroscopy were obtained from secondary research

articles from technical journals as well as Key Opinion Leaders and industry participants. Product

price breakdowns used in the forecast include implants for bony and soft tissue repair and various

instruments used during arthroscopy procedures. The ASP for the US, EU and APAC regions were

obtained through primary research interviews.

Market share

For the base year market, GlobalData’s analysts forecast volumes of arthroscopy implants,

shavers, arthroscopes, radiofrequency wands, advanced visualization systems, and fluid

management systems, which are all products used in the sports medicine surgical setting.

Company market share was then estimated based on revenue for the regional markets within this

report.


Appendix


13.7 About the Authors

13.7.1 Analysts

13.7.1.1 Priya Radhakrishnan, MS, MBA, Senior Analyst, Medical Devices

Priya Radhakrishnan is a Senior Analyst and covers the Orthopedic Devices market at GlobalData

in Boston. Prior to GlobalData, she worked in the non-profit sector and has experience as a

consultant advising French life science firms on assessing business development opportunities in

the US. She has led consulting engagements and created biotech market research reports, as well

as worked at Boston Scientific in a marketing function. Prior to that, she worked as a product

development engineer at an NIH-funded SBIR firm working on gastrointestinal biopsy and

orthopedic devices. Through this experience she developed experience working on animal studies.

And during her Master’s research, she developed an understanding of the mechanical properties of

bone and tissue.

Priya received a B.S. in Biomedical Engineering from Boston University and an M.S. in

Bioengineering with a focus in Biomechanics from the University of Illinois at Chicago. She also

holds an MBA from Boston University’s Graduate School of Management.

13.7.1.2 Derek Archila, MBA, Head of Medical Devices

Derek Archila currently serves as the Head of the Medical Devices team at GlobalData in Boston.

His primary responsibilities include managing the production and quality of the medical databases

and reports, liaising with clients to identify their satisfaction with existing database offerings and

prioritizing critical unmet needs, and supporting GlobalData teams with consulting opportunities. He

is a Board-Certified Medical Technologist with the American Society of Clinical Pathology and

spent the last seven years in the healthcare and medical device industries. Prior to joining

GlobalData, Derek worked as a Senior Medical Technologist at Brigham and Women’s Hospital in

Boston, Massachusetts, where he focused on hematological malignancies and blood disorders.

Derek has worked in various market research and sales roles at DePuy Mitek, Bayer Diagnostics,

LabCorp, and Mettler Toledo. Derek holds a B.S. in Medical Technology and an MBA from

Northeastern’s D’Amore-McKim School of Business.


Appendix


13.7.2 Global Head of Healthcare

13.7.2.1 Bonnie Bain, Ph.D.

Bonnie Bain, PhD, is Global Head of Healthcare for GlobalData in Boston, managing the Medical

and Pharmaceutical arms of the business. Prior to this role, she was Vice President and Global

Research & Analysis Director for Informa, where she oversaw the global strategy and operations

for Datamonitor Healthcare’s syndicated business. Bonnie has over 15 years of experience in the

healthcare sector and a proven track record of developing innovative solutions on both the client

and vendor sides of the business. Prior to joining Informa, she was Director of Product

Development at Wood Mackenzie, where she oversaw the development and management of two

product lines. Bonnie also worked for several years at Decision Resources as an Analyst and

Project Manager. On the client side of the industry, she worked for several years as a Senior

Manager in Marketing Strategy and Analytics at Boston Scientific, where her work contributed to

the successful commercialization of the first-ever Access and Visualization Platform at the

company. She has a PhD in Biochemistry and Molecular Biology from Purdue University, and was

a postdoctoral fellow in molecular pharmacology at the University of Miami School of Medicine.


Appendix


13.8 About MediPoint

MediPoint is the flagship product for GlobalData’s Medical team. Each MediPoint report is built

from the ground up by our team of healthcare analysts in the US and UK. Each report includes

input from experienced physicians and leading Key Opinion Leaders (KOL). Running throughout

each report in the series, “What Do Physicians Think?” quotes provide a unique insight into how

healthcare professionals are reacting to events within the industry, and what their responses could

mean for industry strategists.

13.9 About GlobalData

GlobalData is a leading global provider of business intelligence in the healthcare industry.

GlobalData provides its clients with up-to-date information and analysis on the latest developments

in drug research, disease analysis, and clinical research and development. Our integrated business

intelligence solutions include a range of interactive online databases, analytical tools, reports, and

forecasts. Our analysis is supported by a 24/7 client support and analyst team.

GlobalData has offices in New York, San Francisco, Boston, London, India, Korea, Japan,

Singapore, and Australia.

13.10 Disclaimer

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any

form by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior

permission of the publisher, GlobalData.

Date post:	17-Apr-2020
Category:	Documents
Upload:	others
View:	3 times
Download:	0 times